Tag: FDA

63 posts found

COVID-19 Updates from the FDA

New developments with diagnostic testing and the use of chloroquine and hydroxychloroquine.

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

Does the active ingredient in magic mushrooms have a future in mental health?

With CBD products widely available and advertised for so many ailments, claimants could be using CBD without insurers knowing.

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Indicated for various gastrointestinal concerns, these recalls could impact certain workers’ comp patients.

Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

Orphengesic Forte has received a decision date of August 14, 2019.

Though most forms of marijuana are highly regulated, CBD products are readily available across the country. What does this mean for healthcare?

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

New changes to REMS safety programs will require stronger treatment documentation and oversight.

Prev 1 2 3 4 5 Next